Mytos automates the process of growing human cells. The Mytos platform transforms cell culture from an artisan skillset to an automated and scalable process, ensuring consistent high-quality cells are cultured reliably every time. Mytos' machines are placed on-premise at customer sites, where cells are grown for testing during early-stage drug development. The company's products help teams in drug development and cell therapy save time and costs while increasing the reproducibility of their data.

Mytos was founded in 2016 by two Imperial College London founders and previously backed by YCombinator.